C

Cellivery Therapeutics Inc
KOSDAQ:268600

Watchlist Manager
Cellivery Therapeutics Inc
KOSDAQ:268600
Watchlist
Price: 6 680 KRW -29.91%
Market Cap: ₩594.9m

Dividends

Cellivery Therapeutics Inc
does not pay dividends

Shareholder Yield

Current shareholder yield for Cellivery Therapeutics Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Company Total Yield Dividend Yield Buyback Yield Debt Paydown Yield

Buybacks

Buyback Yield
Cellivery Therapeutics Inc

Period
3Y
5Y
10Y
15Y
30Y
Yield Statistics, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Company Buyback Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Debt Paydown

Debt Paydown Yield
Cellivery Therapeutics Inc

Period
3Y
5Y
10Y
15Y
30Y
Yield Statistics, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Company Debt Paydown Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Price Appreciation

Price
Cellivery Therapeutics Inc

Annual Price Range
6 680
52w Low
N/A
52w High
N/A
Price Metrics
Average Annual Return -65.57%
Standard Deviation of Annual Returns
N/A
Max Drawdown -91%
Shares Statistics
Market Capitalization 594.9m KRW
Shares Outstanding 89 061
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

Stock Splits

Cellivery Therapeutics Inc's latest stock split occurred on Jul 25, 2022

The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.

Before the split, Cellivery Therapeutics Inc traded at 34900 per share. Afterward, the share price was about 16050.

The adjusted shares began trading on Jul 25, 2022. This was Cellivery Therapeutics Inc's 2nd stock split, following the previous one in Feb 1, 2021.

Pre-Split Price
17 450 34 900
Post-Split Price
16 050
Before
After
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett